|
|
Eli Lilly & Co
NYSE •
Healthcare •
Drug Manufacturers - General •
Quote as of 10/23/2026
Company Profile
IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization1,165,229 mln
Float848 mln
Earnings Date10/29/2026
1-Year Forecast
1,331.55
Fairly priced
Key Fundamentals
EPS29.79
P/E42.75
ROE99.90
RPS89.02
ROIC30.81
ROA22.74
Interest Cover131
EBITDA, mln35,996
EV / EBITDA30.21
EV / EBIT32.08
Revenue, mln79,666
EV / Revenue13.65
Quote Details
Last
1,273.46
Change
-33.23 (-2.54%)
Open
1,304.15
Volume
2,266,275
Turnover
2,886,010,368
Average Volume
2,281,070
Financial Ratios
Pre-Tax Profit Margin42
Leverage Ratio4.20
Current Ratio1.36
Price / Book32.44
Price / Tangible Book159
Price / Cash Flow41.52
Price / Free Cash Flow57.61
Debt / Equity1.62
Price / Sales13.31
PEG Ratio1.40
Financial Strength
Altman Z-Score7.97
Piotroski F-Score
9
/ 9
Beneish M-Score-2.04
Price to Intrinsic Value8.51
Price to Lynch Fair Value1.38
Price to Graham Number15.64
1-Year Target Price1,331.55
Shiller PE Ratio124
Short Ratio3.01
Short % of Float0.79
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
1.31% |
73
/ 100
 |
| 1 Month |
7.75% |
88
/ 100
 |
| 2 Months |
11.2% |
89
/ 100
|
| 6 Months |
44.52% |
97
/ 100
 |
| 1 Year |
57.74% |
94
/ 100
 |
|
| |
